Quality of life · Patients with early unfavourable or advanced stage HL
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary malignant neoplasms · Patients with untreated Hodgkin lymphoma (early stages)
Fewer showed no clear difference in secondary malignant neoplasms compared with more courses of chemotherapy (with or without radiotherapy (moderate certainty).
1 finding from 1 review
Death · Patients with untreated Hodgkin lymphoma (early stages)
Fewer showed no clear difference in death compared with more courses of chemotherapy (with or without radiotherapy (high certainty).
1 finding from 1 review
Progression/relapse · Patients with untreated Hodgkin lymphoma (early stages)
Fewer showed no clear difference in progression/relapse compared with more courses of chemotherapy (with or without radiotherapy (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · patients with solid tumours without thrombocytopenia before chemotherapy
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with at least one severe/life‐threatening bleeding episode · patients with solid tumours with thrombocytopenia during chemotherapy
1 finding from 1 review
Intervention not reported
Number of treatment cycles with at least one bleeding episode ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of days on which bleeding occurred ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
The amount of bleeding ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life score ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of patients with at least one bleeding episode of any severity · patients with solid tumours without thrombocytopenia before chemotherapy
It is very uncertain whether the intervention changes number of patients with at least one bleeding episode of any severity (very low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with at least one severe/life‐threatening bleeding episode · patients with solid tumours without thrombocytopenia before chemotherapy
It is very uncertain whether the intervention changes number of patients with at least one severe/life‐threatening… (very low certainty).
1 finding from 1 review
Intervention not reported
Number of treatment cycles with at least one bleeding episode ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of days on which bleeding occurred ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
The amount of bleeding ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life score ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall survival ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of patients with at least one bleeding episode of any severity · patients with solid tumours with thrombocytopenia during chemotherapy
It is very uncertain whether the intervention changes number of patients with at least one bleeding episode of any severity (very low certainty).
1 finding from 1 review
Intervention not reported
Overall survival · people diagnosed with chemotherapy‐induced anemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Hematopoietic response · people diagnosed with chemotherapy‐induced anemia
The intervention leads to higher hematopoietic response (high certainty).
1 finding from 1 review